378 related articles for article (PubMed ID: 28369782)
1. Immune checkpoint proteins: exploring their therapeutic potential to regulate atherosclerosis.
Foks AC; Kuiper J
Br J Pharmacol; 2017 Nov; 174(22):3940-3955. PubMed ID: 28369782
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic lymphocytes and atherosclerosis: significance, mechanisms and therapeutic challenges.
Kyaw T; Peter K; Li Y; Tipping P; Toh BH; Bobik A
Br J Pharmacol; 2017 Nov; 174(22):3956-3972. PubMed ID: 28471481
[TBL] [Abstract][Full Text] [Related]
3. Readapting the adaptive immune response - therapeutic strategies for atherosclerosis.
Sage AP; Mallat Z
Br J Pharmacol; 2017 Nov; 174(22):3926-3939. PubMed ID: 28052311
[TBL] [Abstract][Full Text] [Related]
4. Anti-atherosclerotic effect of the angiotensin 1-7 mimetic AVE0991 is mediated by inhibition of perivascular and plaque inflammation in early atherosclerosis.
Skiba DS; Nosalski R; Mikolajczyk TP; Siedlinski M; Rios FJ; Montezano AC; Jawien J; Olszanecki R; Korbut R; Czesnikiewicz-Guzik M; Touyz RM; Guzik TJ
Br J Pharmacol; 2017 Nov; 174(22):4055-4069. PubMed ID: 27935022
[TBL] [Abstract][Full Text] [Related]
5. Aspirin-triggered lipoxin A4 inhibits atherosclerosis progression in apolipoprotein E
Petri MH; Laguna-Fernandez A; Arnardottir H; Wheelock CE; Perretti M; Hansson GK; Bäck M
Br J Pharmacol; 2017 Nov; 174(22):4043-4054. PubMed ID: 28071789
[TBL] [Abstract][Full Text] [Related]
6. Targeting inflammation to reduce cardiovascular disease risk: a realistic clinical prospect?
Welsh P; Grassia G; Botha S; Sattar N; Maffia P
Br J Pharmacol; 2017 Nov; 174(22):3898-3913. PubMed ID: 28409825
[TBL] [Abstract][Full Text] [Related]
7. Targeting inflammation to reduce cardiovascular disease risk.
Maffia P; Cirino G
Br J Pharmacol; 2017 Nov; 174(22):3895-3897. PubMed ID: 29080212
[TBL] [Abstract][Full Text] [Related]
8. T-cell immunity in myocardial inflammation: pathogenic role and therapeutic manipulation.
Stephenson E; Savvatis K; Mohiddin SA; Marelli-Berg FM
Br J Pharmacol; 2017 Nov; 174(22):3914-3925. PubMed ID: 27590129
[TBL] [Abstract][Full Text] [Related]
9. The role of the mineralocorticoid receptor in immune cells in cardiovascular disease.
van der Heijden CDCC; Bode M; Riksen NP; Wenzel UO
Br J Pharmacol; 2022 Jul; 179(13):3135-3151. PubMed ID: 34935128
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide and hydrogen sulfide: the gasotransmitter paradigm of the vascular system.
Cirino G; Vellecco V; Bucci M
Br J Pharmacol; 2017 Nov; 174(22):4021-4031. PubMed ID: 28407204
[TBL] [Abstract][Full Text] [Related]
11. Vascular inflammation and low-density lipoproteins: is cholesterol the link? A lesson from the clinical trials.
Catapano AL; Pirillo A; Norata GD
Br J Pharmacol; 2017 Nov; 174(22):3973-3985. PubMed ID: 28369752
[TBL] [Abstract][Full Text] [Related]
12. Unravelling the adiponectin paradox: novel roles of adiponectin in the regulation of cardiovascular disease.
Woodward L; Akoumianakis I; Antoniades C
Br J Pharmacol; 2017 Nov; 174(22):4007-4020. PubMed ID: 27629236
[TBL] [Abstract][Full Text] [Related]
13. Current and future therapies for addressing the effects of inflammation on HDL cholesterol metabolism.
Iqbal F; Baker WS; Khan MI; Thukuntla S; McKinney KH; Abate N; Tuvdendorj D
Br J Pharmacol; 2017 Nov; 174(22):3986-4006. PubMed ID: 28326542
[TBL] [Abstract][Full Text] [Related]
14. Contribution of the commensal microbiota to atherosclerosis and arterial thrombosis.
Kiouptsi K; Reinhardt C
Br J Pharmacol; 2018 Dec; 175(24):4439-4449. PubMed ID: 30129122
[TBL] [Abstract][Full Text] [Related]
15. Role of immune cells in hypertension.
Caillon A; Paradis P; Schiffrin EL
Br J Pharmacol; 2019 Jun; 176(12):1818-1828. PubMed ID: 29952002
[TBL] [Abstract][Full Text] [Related]
16. A chalcone derivative, 1m-6, exhibits atheroprotective effects by increasing cholesterol efflux and reducing inflammation-induced endothelial dysfunction.
Chen LW; Tsai MC; Chern CY; Tsao TP; Lin FY; Chen SJ; Tsui PF; Liu YW; Lu HJ; Wu WL; Lin WS; Tsai CS; Lin CS
Br J Pharmacol; 2020 Dec; 177(23):5375-5392. PubMed ID: 32579243
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of microsomal PGE synthase-1 reduces human vascular tone by increasing PGI
Ozen G; Gomez I; Daci A; Deschildre C; Boubaya L; Teskin O; Uydeş-Doğan BS; Jakobsson PJ; Longrois D; Topal G; Norel X
Br J Pharmacol; 2017 Nov; 174(22):4087-4098. PubMed ID: 28675448
[TBL] [Abstract][Full Text] [Related]
18. Metabolic profiling of murine plasma reveals eicosapentaenoic acid metabolites protecting against endothelial activation and atherosclerosis.
Liu Y; Fang X; Zhang X; Huang J; He J; Peng L; Ye C; Wang Y; Xue F; Ai D; Li D; Zhu Y
Br J Pharmacol; 2018 Apr; 175(8):1190-1204. PubMed ID: 28771708
[TBL] [Abstract][Full Text] [Related]
19. Endothelial cell and T-cell crosstalk: Targeting metabolism as a therapeutic approach in chronic inflammation.
Certo M; Elkafrawy H; Pucino V; Cucchi D; Cheung KCP; Mauro C
Br J Pharmacol; 2021 May; 178(10):2041-2059. PubMed ID: 31999357
[TBL] [Abstract][Full Text] [Related]
20. WNT signalling: mechanisms and therapeutic opportunities.
Schulte G; Bryja V
Br J Pharmacol; 2017 Dec; 174(24):4543-4546. PubMed ID: 29235106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
